Sts-/- mice

Background

Phosphatases Sts-1 and Sts-2 are two homologous proteins in humans which act as negative regulators of T cell receptor (TCR) signaling. These proteins regulate immune signaling through activity catalyzed by their shared C-terminal histidine phosphatase (HP) domain. The HP domain is a tyrosine phosphatase which dephosphorylates the kinases Syk and ZAP-70.

Technology

Dr. Nicholas Carpino developed a novel mouse model that has demonstrated resistance to systemic infection by human fungal pathogen Candida albicans, Gram-negative bacterial pathogen Francisella tularensis, and Gram-positive pathogen Staphylococcus aureus. The mouse model presents the double knockout of Sts-1 and Sts-2. This modification increases ZAP-70 phosphorylation and activation, which leads to enhanced downstream TCR signaling and elevated cytokine production. The absence of these proteins results in a marked increase in T cell proliferation and altered immune signaling pathways. These mutations enable the mice to withstand lethal inoculums of dangerous pathogens.

Advantages

Useful for testing novel compounds and treatment strategies - Provides a better suited animal model for studying antimicrobial immunity

Application

Mouse Model - Research Tool - Therapeutic Screening - Drug Delivery

Patent Status

Stage Of Development

Licensing Potential

Development partner - Commercial partner - Licensing

Licensing Status

Available

Additional Info

https://stonybrook.technologypublisher.com/files/sites/050-9446.png
Reduced size of Staphylococcus abscess communities within Sts-/- mouse kidney abscesses

Category(s):

Campus > Stony Brook University

Case ID: R050-9446

Bookmark this page

Download as PDF

For Information, Contact:

Valery Matthys

Licensing Associate

State University of New York at Stony Brook

valery.matthys@stonybrook.edu

Inventors:

Nick Carpino